Literature DB >> 10160106

Do physicians' perceptions of drug costs influence their prescribing?

M Ryan1, B Yule, C Bond, R J Taylor.   

Abstract

This study examines general practitioner (GP) attitudes towards and knowledge of prescribing costs, and the influence of these 2 factors in the doctor's demand for drugs. The main emphasis of the study is on the influence of perceived cost of drugs on prescribing habits. A postal questionnaire was sent to all 273 GP principals in the Grampian region of Scotland. This questionnaire assessed GPs' attitudes and knowledge with respect to prescribing costs. Information was also collected on the prescribing habits of 176 of these GPs. This information was linked to look at the influence GPs' knowledge of drug costs has on their actual prescribing behaviour. Three drug groups were studied: ulcer-healing drugs, pain-killers and penicillins. The results showed that although most GPs agreed that costs should be borne in mind when prescribing medicines, their actual knowledge of the drug costs was often inaccurate. Furthermore, for certain therapeutic groups, prescribing habits are influenced by GPs' perceptions of drug costs. This implies that GPs are not as averse to considering costs as is often assumed, and that giving GPs better information about drug costs might promote more rational prescribing.

Entities:  

Mesh:

Year:  1996        PMID: 10160106     DOI: 10.2165/00019053-199609040-00005

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  23 in total

1.  Change in the established prescribing habits of general practitioners: an analysis of initial prescriptions in general practice.

Authors:  R J Taylor; C M Bond
Journal:  Br J Gen Pract       Date:  1991-06       Impact factor: 5.386

2.  A survey of physicians' awareness of drug costs.

Authors:  D R Lowy; L Lowy; R S Warner
Journal:  J Med Educ       Date:  1972-05

3.  Influence of simple computerized feedback on prescription charges in an ambulatory clinic. A randomized clinical trial.

Authors:  C O Hershey; D K Porter; D Breslau; D I Cohen
Journal:  Med Care       Date:  1986-06       Impact factor: 2.983

4.  Costs of diagnostic tests: estimates by health professionals.

Authors:  W O Robertson
Journal:  Med Care       Date:  1980-05       Impact factor: 2.983

5.  The interaction among the criteria physicians use when prescribing.

Authors:  R N Zelnio
Journal:  Med Care       Date:  1982-03       Impact factor: 2.983

6.  Prescribers' beliefs and values as predictors of drug choices.

Authors:  R Segal; C D Hepler
Journal:  Am J Hosp Pharm       Date:  1982-11

7.  How physicians choose drugs.

Authors:  P Denig; F M Haaijer-Ruskamp; D H Zijsling
Journal:  Soc Sci Med       Date:  1988       Impact factor: 4.634

8.  Drug choice as a problem-solving process.

Authors:  R Segal; C D Hepler
Journal:  Med Care       Date:  1985-08       Impact factor: 2.983

9.  Physicians' knowledge of drug costs for the elderly.

Authors:  L Glickman; E A Bruce; F G Caro; J Avorn
Journal:  J Am Geriatr Soc       Date:  1994-09       Impact factor: 5.562

10.  The family physician's knowledge of the cost of prescribed drugs.

Authors:  G L Oppenheim; S H Erickson; C Ashworth
Journal:  J Fam Pract       Date:  1981-06       Impact factor: 0.493

View more
  3 in total

1.  Prescribing behaviour after the introduction of decentralized drug budgets: is there an association with employer and type of care facility?

Authors:  Karolina Andersson; Anders Carlsten; Tove Hedenrud
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581

2.  The cost of medicines in the United Kingdom. A survey of general practitioners' opinions and knowledge.

Authors:  J Silcock; M Ryan; C M Bond; R J Taylor
Journal:  Pharmacoeconomics       Date:  1997-01       Impact factor: 4.981

3.  The influence of hospital-based prescribers on prescribing in general practice.

Authors:  J Feely; R Chan; J McManus; B O'Shea
Journal:  Pharmacoeconomics       Date:  1999-08       Impact factor: 4.981

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.